Vor Biopharma VOR Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vor Biopharma's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vor Biopharma's total liabilities?
- Vor Biopharma (VOR) reported total liabilities of $657.17M in Q1 2026.
- How has Vor Biopharma's total liabilities changed year-over-year?
- Vor Biopharma's total liabilities increased by 1419.7% year-over-year, from $43.24M to $657.17M.
- What is the long-term trend for Vor Biopharma's total liabilities?
- Over 5 years (2020 to 2025), Vor Biopharma's total liabilities has grown at a 86.8% compound annual growth rate (CAGR), from $27.64M to $628.44M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.